Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Thymus Transplantation With Immunosuppression, #950

NCT00579527 is registered in ClinicalTrials.gov with Sumitomo Pharma Switzerland GmbH as lead sponsor.

NCT NCT00579527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00579527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Thymus Transplantation With Immunosuppression, #950
Lead sponsor
Sumitomo Pharma Switzerland GmbH
Phase
Phase 1/2
Overall status
Completed
Start date
December 19, 2005
Completion date
December 31, 2017
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complete atypical digeorge anomaly, complete atypical digeorge syndrome, complete digeorge anomaly, complete digeorge syndrome, digeorge anomaly